Worlds Third-Largest OTC Player Sanofis Consumer Health Unit Nears 16B Deal With Clayton Dubilier Rice - Yahoo Finance
SANOFICONR | 4,800 32.70 0.68% |
About 62% of SANOFI S's investor base is looking to short. The analysis of current outlook of investing in SANOFI S HEALTHC suggests that many traders are alarmed regarding SANOFI S's prospects. The current market sentiment, together with SANOFI S's historical and current headlines, can help investors time the market. In addition, many technical investors use SANOFI S HEALTHC stock news signals to limit their universe of possible portfolio assets.
SANOFI |
Worlds Third-Largest OTC Player Sanofis Consumer Health Unit Nears 16B Deal With Clayton Dubilier Rice Yahoo Finance
Read at news.google.com
SANOFI S Fundamental Analysis
We analyze SANOFI S's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SANOFI S using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SANOFI S based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
SANOFI S is rated below average in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
SANOFI S HEALTHC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SANOFI S stock to make a market-neutral strategy. Peer analysis of SANOFI S could also be used in its relative valuation, which is a method of valuing SANOFI S by comparing valuation metrics with similar companies.
Peers
SANOFI S Related Equities
INDIAGLYCO | India Glycols | 3.95 | ||||
BFINVEST | BF Investment | 1.52 | ||||
ALKALI | Alkali Metals | 0.87 | ||||
SANOFICONR | SANOFI S | 0.68 | ||||
KNRCON | KNR Constructions | 1.00 | ||||
FINOPB | Fino Payments | 1.17 | ||||
MANGCHEFER | Mangalore Chemicals | 1.61 | ||||
KINGFA | Kingfa Science | 1.76 | ||||
INDOBORAX | Indo Borax | 2.01 | ||||
KREBSBIO | Krebs Biochemicals | 2.15 |
Complementary Tools for SANOFI Stock analysis
When running SANOFI S's price analysis, check to measure SANOFI S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SANOFI S is operating at the current time. Most of SANOFI S's value examination focuses on studying past and present price action to predict the probability of SANOFI S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SANOFI S's price. Additionally, you may evaluate how the addition of SANOFI S to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |